Go Back   2023 2024 Courses.Ind.In > Main Category > Main Forum

  #1  
Old June 22nd, 2016, 04:49 PM
Senior Member
 
Join Date: May 2013
Default Amgen Bite Technology

Discuss about amgen bite technology here. Welcome to Courses.ind.in and this page is for amgen bite technology discussion. If you are looking for information on amgen bite technology then ask your question is as much details as possible in the “Reply” box provided below. The more detailed your question will be, the more easy will it be for our experts to answers your query. And if you have any updated or latest information on amgen bite technology, then please share you knowledge with our experts in the “Reply” box below. Your reply will be published here and your knowledge can help many people. Thanks for stopping by at Courses.ind.in. Please visit again.
Reply With Quote Quick reply to this message
  #2  
Old February 27th, 2018, 11:48 AM
Unregistered
Guest
 
Default Re: amgen bite technology

I shifted to Thousand Oaks, CA and came to know about the Amgen Bite Technology which is related to Cancer Cells. Will you please provide me basic details about Cancer Cells Amgen Bite Technology and also provide complete address and contact details of Amgen Inc. Corporation?
Reply With Quote Quick reply to this message
  #3  
Old February 27th, 2018, 11:49 AM
Super Moderator
 
Join Date: Aug 2012
Default Re: amgen bite technology

BiTE® Antibodies: Designed to Bridge T Cells to Cancer Cells
An Investigational Technology from Amgen

Cytotoxic T-Lymphocytes (CTLs) have an innate ability to target tumor cells, and evidence supports a role for immunosurveillance in tumor targeting.

By recognizing and binding to tumor cells, CTLs can lead to tumor cell lysis.

Tumor cells can evade destruction by cytotoxic T cells
Modification of tumor microenvironment by secretion of immunosuppressive cytokines such as TGF-β2
Modification of immune cell repertoire by stimulation of immunosuppressive response2,3
Generation of IDO2
Loss or mutation of MHC class I on tumor cells2
Interference with perforin/granzyme pathway4,5
Exploitation of immune-checkpoint proteins
Increased CTLA-4 expression on T cells counteracts CD284
Increased PD-1 expression on T cells4
Inhibition of kinases involved in T cell activation5
Persistent PD-1 expression causing T cell exhaustive state5
Increased PD-L1 expression on tumor cell surface4

Contact:

Corporate Headquarters
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Phone: +1 805-447-1000
Fax: +1 805-447-1010
Reply With Quote Quick reply to this message
Reply
Similar Threads
Thread
Department Of Information Technology Md
MBA Information Technology NJ
accenture technology services
is vellore institute of technology bad
www vellore institute of technology edu
fujian university of technology
MBA Texas A&M MBA IT technology
rai technology university
institute of technology (iit) varanasi
information technology department up
burdwan university technology
uga information technology department
the lnm institute of information technology
Kalpataru Institute of Technology
what is nautical technology
MBA Pharmaceutical Technology
Universities in UK for Petroleum Technology
PSC technology m sdn Bhd
Thaper Institute Of Technology
IES institute of technology


Quick Reply
Your Username: Click here to log in

Message:
Options



All times are GMT +5.5. The time now is 10:16 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Search Engine Friendly URLs by vBSEO 3.6.1
vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.